Aetiology and pathology of systemic lupus erythematosus

Hospital Pharmacist

Volumn 8, Issue 3, 2001, Pages 62-68

  Silva, C ^a   Isenberg, D A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; CLINICAL FEATURE; ENVIRONMENTAL FACTOR; HEREDITY; MORBIDITY; PATHOGENESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0035074196     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Genetic susceptibility to systemic lupus erythematosus
2. Does the black population in Africa get SLE. If not, why not?
3. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth
4. Systemic lupus erythematosus
5. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus
6. A novel polymorphism of FcγRIIIA, which alters function, associated with the SLE phenotype
7. A genome-wide search for susceptibility genes in human systemic lupus erythematosus pair families
8. Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analyses of 187 sib-pair families
9. Genome scan of human systemic lupus erythematosus: Evidence for a linkage on chromosome lq in African-American pedigrees
10. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families
11. The origin, sequence, structure and consequences of developing anti-DNA antibodies
12. Anti-DNA and autoantibodies
13. Lupus nephritis: Update on pathogenesis and disease mechanisms
14. Nephritogenic autoantibodies in lupus: Current concepts and continuing controversies
15. Autoimmunity against nucleosomes and lupus nephritis
16. Lupus nephritis
17. Autoantibodies in systemic lupus erythematosus
18. Mechanisms of cellular penetration and nuclear localisation of an anti-double strand DNA autoantibody
19. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo
20. The T cell enigma in lupus
21. Changes in subset specificity of anti-T cell autoantibodies in systemic lupus erythematosus
22. Immune cell signaling in lupus
23. Cytokines and systemic lupus erythematosus
24. Lymphocytes, cytokines, inflammation, and immune trafficking
25. Apoptosis in human autoimmune diseases
26. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
27. Accelerated programmed cell death of MRL-1pr-1pr T lymphocytes
28. High levels of Bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus
29. Enforced Bcl-2 expression in B lymphoid cell prolongs antibody responses and elicits autoimmune disease
30. Immunopathogenesis of SLE
31. Elevated soluble Fas production in SLE correlates with HLA status and not with disease activity
32. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease
33. Analysis of Fas ligand gene mutation in patients with systemic lupus erythematosus
34. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus
35. Adhesion molecules in autoimmune disease
36. Lymphocyte adhesion molecules in autoimmune rheumatic diseases: Basic issues and clinical expectations
37. Integrin signalling defects in T lymphocytes in systemic lupus erythematosus
38. Neuroendocrine changes in systemic lupus erythematosus and Sjögren's syndrome
39. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures
40. Estrogen enhancement of anti-double stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
41. Autoantibodies in systemic lupus erythematosus
42. Initiation of autoimmunity to the p53 tumour suppressor protein by complexes of p53 and SV40 large T antigen
43. Autoepitopes in lupus
44. Can immunisation precipitate connective tissue disease? Report of five cases and review of the literature
45. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible aetiology for systemic lupus erythematosus
46. Systemic lupus erythematosus and related disorders